ABBV vs ATOM · P/E 81, rev $61.16B vs rev $135.0K
AbbVie Inc (ABBV) versus Atomera Inc (ATOM) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ATOM currently screens at market cap $341.1M.
Not investment advice. Open the ABBV and ATOM stock pages for the full models.
Not investment advice.